First Allied Asset Management’s Novartis NVS Stock Holding History

First Allied Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,405	Closed	-$381K	–	99
2015 Q1	$381K	Buy	4,405 +973	+28%	+$86.3K	0.05%	152
2014 Q4	$280K	Sell	3,432 -245	-7%	-$20.3K	0.04%	161
2014 Q3	$309K	Buy	+3,677	New	+$297K	0.04%	181

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

First Allied Asset Management's NVS Position: Q2 2015 in Review

First Allied Asset Management sold out of Novartis (NVS) in Q2 2015, closing a stake of 4,405 shares — an estimated $381K sold.

First Allied Asset Management first reported a position in NVS in Q3 2014 and held it in 3 quarters. The position peaked at $381K in Q1 2015. 944 funds tracked by Wall St. Rank hold NVS as of Q2 2015.

First Allied Asset Management reported no remaining Novartis position as of Q2 2015 after selling out during the quarter.
First Allied Asset Management sold 4,405 Novartis shares in Q2 2015, an estimated $381K.
First Allied Asset Management first reported a position in Novartis in Q3 2014 and held it in 3 quarters.
First Allied Asset Management's Novartis position peaked at $381K in Q1 2015.
944 funds tracked by Wall St. Rank held Novartis as of Q2 2015.

Based on First Allied Asset Management's 13F filing for Q2 2015.